-
Mashup Score: 2News from virtual ERS: Novel inhaled therapies, long-term COVID-19 follow-up and more - 4 year(s) ago
The Healio editors have compiled a list of the most-read pulmonology news from the recent virtual European Respiratory Society International Congress.Highlights from the virtual meeting including the later-life impact of childhood bronchitis, gefapixant for refractory or unexplained chronic cough and the benefit of inhaled molgramostim in autoimmune pulmonary alveolar proteinosis. Other
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0News from virtual ERS: Novel inhaled therapies, long-term COVID-19 follow-up and more - 4 year(s) ago
The Healio editors have compiled a list of the most-read pulmonology news from the recent virtual European Respiratory Society International Congress.Highlights from the virtual meeting including the later-life impact of childhood bronchitis, gefapixant for refractory or unexplained chronic cough and the benefit of inhaled molgramostim in autoimmune pulmonary alveolar proteinosis. Other
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
Healio editors compiled a list of the most-read pulmonology news from the European Respiratory Society International Congress. Check out what Healio readers were most interested in below! #ERS2020 #Pneumonia #Covid19 #ChronicCough #Smoking #asthma https://t.co/pL3G3toIkp
-
Healio editors compiled a list of the most-read pulmonology news from the European Respiratory Society International Congress. Check out what Healio readers were most interested in below! #ERS2020 #Pneumonia #Covid19 #ChronicCough #Smoking #asthma https://t.co/TJhszMV1kz
-
-
Mashup Score: 4Top news of September: COVID-19 long-term follow-up, novel chronic cough therapy and more - 4 year(s) ago
The Healio editors have compiled a list of the most-read pulmonology news published in September.Healio readers last month were most interested in new research on structured follow-up for COVID-19 survivors and guidance on long-term noninvasive ventilation for patients with chronic stable hypercapnic COPD. Other highlights include news from the virtual European Respiratory Society Congress on a
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Healio editors compiled a list of the most-read pulmonology news published in September. Check out what Healio readers were most interested in below! #asthma #Covid19 #ERS2020 #COPD #Pneumonia #Smoking https://t.co/ShM0vzgJun
-
-
Mashup Score: 0Top news of September: COVID-19 long-term follow-up, novel chronic cough therapy and more - 4 year(s) ago
The Healio editors have compiled a list of the most-read pulmonology news published in September.Healio readers last month were most interested in new research on structured follow-up for COVID-19 survivors and guidance on long-term noninvasive ventilation for patients with chronic stable hypercapnic COPD. Other highlights include news from the virtual European Respiratory Society Congress on a
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
Healio editors compiled a list of the most-read pulmonology news published in September. Check out what Healio readers were most interested in below! #asthma #Covid19 #ERS2020 #COPD #Pneumonia #Smoking https://t.co/seUW1NcqXG
-
Healio editors compiled a list of the most-read pulmonology news published in September. Check out what Healio readers were most interested in below! #asthma #Covid19 #ERS2020 #COPD #Pneumonia #Smoking https://t.co/DEBeunexn8
-
-
Mashup Score: 0
Home-based telerehabilitation demonstrated improved quality of life but was not confirmed to be equivalent to center-based pulmonary rehabilitation, researchers reported at the virtual European Respiratory Society International Congress.“The aim of our trial was to investigate whether home-based telerehabilitation achieved equivalent outcomes to center-based pulmonary rehabilitation in
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
#Telerehabilitation demonstrated improved quality of life but was not confirmed to be equivalent to center-based #pulmonary rehabilitation, presented at the virtual European Respiratory Society International Congress. #ERS2020 https://t.co/1lFbB2LhGV
-
-
Mashup Score: 0
Early exposure to high levels of air pollution may be associated with reduced lung function during adolescence, researchers reported at the virtual European Respiratory Society International Congress.“The adverse effects of early-life air pollution exposure may persist up to adolescence with a variety of adverse outcomes such as asthma,” Qi Zhao, MD, adjunct research fellow in the
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Early exposure to high levels of air #pollution may be associated with reduced #lung function during #adolescence, presented at the virtual European Respiratory Society International Congress. #ERS2020 https://t.co/pLlDtsJbgW
-
-
Mashup Score: 2ISCHEMIA Revisited: Some May Benefit From Invasive Strategy - 4 year(s) ago
A prespecified subanalysis from the landmark ISCHEMIA trial shows that a subgroup of patients might actually benefit from immediate revascularization.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Immediate revascularization shows promise in landmark ISCHEMIA trial. https://t.co/uoJzCTSL1v #ERS2020
-
-
Mashup Score: 3ISCHEMIA Revisited: Some May Benefit From Invasive Strategy - 4 year(s) ago
A prespecified subanalysis from the landmark ISCHEMIA trial shows that a subgroup of patients might actually benefit from immediate revascularization.
Source: MedscapeCategories: Latest Headlines, SurgeryTweet-
Immediate revascularization shows promise in landmark ISCHEMIA trial. https://t.co/uoI0gWOoal #ERS2020
-
-
Mashup Score: 2ISCHEMIA Revisited: Some May Benefit From Invasive Strategy - 4 year(s) ago
A prespecified subanalysis from the landmark ISCHEMIA trial shows that a subgroup of patients might actually benefit from immediate revascularization.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Immediate revascularization shows promise in landmark ISCHEMIA trial. https://t.co/4fjXg4Qz8Y #ERS2020
-
-
Mashup Score: 8Oral Masitinib Phase 3 Results Promising for Severe Asthma - 4 year(s) ago
The tyrosine kinase inhibitor reduced severe exacerbations by 35%, regardless of eosinophil count, in a population that hasn’t had an effective oral treatment option, new research shows.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
STUDY: The tyrosine kinase inhibitor reduced severe asthma exacerbations by 35%. https://t.co/dVanDi3qv4 #ERSCongress #ers2020
-
Healio editors compiled a list of the most-read pulmonology news from the European Respiratory Society International Congress. Check out what Healio readers were most interested in below! #ERS2020 #Pneumonia #Covid19 #ChronicCough #Smoking https://t.co/siHrlhZR5Q